The Centre for Drug Administration (CDA)safeguards public health by ensuring that medicinal and health-related products in Singapore meet appropriate standards of safety, quality and efficacy.
CDA carries out pre-marketing evaluation of medicinal products before they are allowed to be marketed in Singapore. Products currently regulated include western medicinal products, Chinese proprietary medicines and cosmetic products. The regulatory framework for health supplements is being developed. CDA is also responsible for the regulation of clinical trials in Singapore and the provision of unbiased drug information to health professionals and the public.
